Abstract:Intracellular protein trafficking plays an important role in neuronal function and survival. Protein misfolding is a common theme found in many neurodegenerative diseases, and intracellular trafficking machinery contributes to the pathological accumulation and clearance of misfolded proteins. Although neurodegenerative diseases exhibit distinct pathological features, abnormal endocytic trafficking is apparent in several neurodegenerative diseases, such as Alzheimer's disease (AD), Down syndrome (DS) and Parkinson's disease (PD). In this review, we will focus on protein sorting defects in three major neurodegenerative diseases, including AD, DS and PD. An important pathological feature of AD is the presence of extracellular senile plaques in the brain. Senile plaques are composed of β-amyloid (Aβ) peptide aggregates. Multiple lines of evidence demonstrate that over-production/aggregation of Aβ in the brain is a primary cause of AD and attenuation of Aβ generation has become a topic of extreme interest in AD research. Aβ is generated from β-amyloid precursor protein (APP) through sequential cleavage by β-secretase and the γ-secretase complex. Alternatively, APP can be cleaved by α-secretase within the Aβ domain to release soluble APPα which precludes Aβ generation. DS patients display a strikingly similar pathology to AD patients, including the generation of neuronal amyloid plaques. Moreover, all DS patients develop an AD-like neuropathology by their 40 s. Therefore, understanding the metabolism/processing of APP and how these underlying mechanisms may be pathologically compromised is crucial for future AD and DS therapeutic strategies. Evidence accumulated thus far reveals that synaptic vesicle regulation, endocytic trafficking, and lysosome-mediated autophagy are involved in increased susceptibility to PD. Here we review current knowledge of endosomal trafficking regulation in AD, DS and PD.

Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases

The Ubiquitin Proteasome System As a Potential Target for the Treatment of Neurodegenerative Diseases

The Ubiquitin–Proteasome System in Synapses

Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease

The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer’s disease

Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer’s disease

Proteasomal Dysfunction in Aging and Huntington Disease

The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease

Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases

Copper Homeostasis and the Ubiquitin Proteasome System

Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention

Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis

Protein Misfolding and Neurodegenerative Diseases

The Molecular Mechanisms of Ubiquitin-Proteasome System Effecting on Cognition

Exploring the Role of Ubiquitin–Proteasome System in Parkinson's Disease

Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.

The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases

Impaired Ubiquitin–proteasome System Activity in the Synapses of Huntington's Disease Mice

Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.

Dysregulation of Protein Trafficking in Neurodegeneration